From Innovation to Industry

Modern Perspectives and Challenges of Patent Law in Regulating Biotechnology

Abstract

This paper investigates the role of contemporary patent law in the biotechnology sector and its intersecting industries, establishing a foundational overview of patent rights and tracing the evolution of their Intellectual Property (IP) frameworks in the United States. A discussion of the revolutionary CRISPR-Cas9 gene-editing technology serves as a case study for analyzing the role of patents in market dynamics, incentives for innovation, and broader ethical implications. Through this dissection of IP fundamentals in biotech, this paper sheds light on the challenges of balancing private and public interest while addressing the evolving technological landscape.